Patents by Inventor David L. Suter

David L. Suter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of peripheral vascular disease using protein solutions
    Patent number: 10441634
    Abstract: Methods of treating peripheral vascular disease comprising administering a protein solution site of a defect at least two proteins from the group IL-1ra, sTNF-RI, sTNF-RII, IGF-I, EGF, HGF, PDGF-AB, PDGF-BB, VEGF, TGF-?1, and sIL-1RII. The solution may also comprise white blood cells, platelets, concentrated bone marrow aspirate, and combinations thereof.
    Type: Grant
    Filed: December 8, 2017
    Date of Patent: October 15, 2019
    Assignee: Biomet Biologics, LLC
    Inventors: Matthew D. Landrigan, Krista Toler, Jennifer E. Woodell-May, David L. Suter
  • TREATMENT OF PERIPHERAL VASCULAR DISEASE USING PROTEIN SOLUTIONS
    Publication number: 20180099026
    Abstract: Methods of treating peripheral vascular disease comprising administering a protein solution site of a defect at least two proteins from the group IL-1ra, sTNF-RI, sTNF-RII, IGF-I, EGF, HGF, PDGF-AB, PDGF-BB, VEGF, TGF-?1, and sIL-1RII. The solution may also comprise white blood cells, platelets, concentrated bone marrow aspirate, and combinations thereof.
    Type: Application
    Filed: December 8, 2017
    Publication date: April 12, 2018
    Inventors: Matthew D. Landrigan, Krista Toler, Jennifer E. Woodell-May, David L. Suter
  • Treatment of peripheral vascular disease using protein solutions
    Patent number: 9895418
    Abstract: Methods of treating peripheral vascular disease comprising administering a protein solution site of a defect at least two proteins from the group IL-1ra, sTNF-RI, sTNF-RII, IGF-I, EGF, HGF, PDGF-AB, PDGF-BB, VEGF, TGF-?1, and sIL-1RII. The solution may also comprise white blood cells, platelets, concentrated bone marrow aspirate, and combinations thereof.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: February 20, 2018
    Assignee: Biomet Biologics, LLC
    Inventors: Matthew D. Landrigan, Krista O'Shaughnessey, Jennifer E. Woodell-May, David L. Suter
  • TREATMENT OF PERIPHERAL VASCULAR DISEASE USING PROTEIN SOLUTIONS
    Publication number: 20140271588
    Abstract: Methods of treating peripheral vascular disease comprising administering a protein solution site of a defect at least two proteins from the group IL-1ra, sTNF-RI, sTNF-RII, IGF-I, EGF, HGF, PDGF-AB, PDGF-BB, VEGF, TGF-?1, and sIL-1RII. The solution may also comprise white blood cells, platelets, concentrated bone marrow aspirate, and combinations thereof.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 18, 2014
    Inventors: Matthew D. LANDRIGAN, Krista O'SHAUGHNESSEY, Jennifer E. WOODELL-MAY, David L. SUTER
  • Palatable solid pharmaceutical compositions
    Patent number: 4786502
    Abstract: Lipid-containing, molded pharmaceutical compositions, comprising:(a) from about 10% to about 50% of a lipid material having a melting point of from about 26.degree. C. to about 37.degree. C.;(b) from about 10% to about 50% of a particulate dispersant material;(c) from about 0.1% to about 3% of an emulsifier; and(d) a safe and effective amount of a pharmaceutical active material;wherein the particulate materials in said composition have a mean particle size of from about 4 microns to about 10 microns, with less than about 10% of the particulates greater than about 30 microns in size. Preferably, the measured viscosity of the compositions is less than about 10,000 cps at about 40.degree. C.
    Type: Grant
    Filed: October 6, 1986
    Date of Patent: November 22, 1988
    Assignee: The Procter & Gamble Company
    Inventors: Francis B. Chapura, Charles W. Bishop, Kenneth Charak, Phillip F. Pflaumer, David L. Suter